MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity
MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore the potential of mitochondrial sulfide donors in addressing obesity-related disorders.
More
Harwell Science and Innovation Campus shortlisted for best public-private partnership
Harwell Science and Innovation Campus has been shortlisted for Best Public-Private Partnership at the Life Science, Tech and Research Clusters Awards, recognising the strength of its collaborative model and its role in driving scientific excellence, economic growth, and long-term societal impact. The nomination reflects the success of the long-standing partnership […]
Help to Grow Your Business with Oxford Brookes University
Help to Grow: Management – Starting 2 June Small business leaders across Oxfordshire now have the opportunity to join a proven, government‑backed leadership programme designed to support ambitious growth. Oxford Brookes University Business School is recruiting for the next cohort of Help to Grow: Management, a 12‑week leadership and management programme created specifically for SME leaders […]
Harwell Campus launches public consultation to shape its vision as it looks to its centenary
Harwell Science and Innovation Campus has launched a public consultation inviting local communities, businesses and stakeholders to help shape the next chapter of its long-term plans, as the campus looks ahead to its 100th anniversary. Building on more than 80 years at the forefront of UK scientific discovery, Harwell is […]